Electronic ISSN 2287-0237

VOLUME

INCREASING DEMAND FOR MSI TESTING AND PREVALENCE OF MSI-H CANCERS IN THAI PATIENTS: EXPERIENCE AT CHULALONGKORN GENEPRO CENTER

SEPTEMBER 2018 - VOL.14 | ORIGINAL ARTICLE
  1. Hause RJ, Pritchard CC, Shendure J, et al. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med 2016;22(11):1342-50.
  2. Choi YY, Bae JM, An JY, et al. Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis. J Surg Oncol 2014;110(2):129-35. 
  3. Kloor M, Staffa L, Ahadova A, et al. Clinical significance of microsatellite instability in colorectal cancer. Langenbecks Arch Surg 2014;399(1):23-31.
  4. Malesci A, Laghi L, Bianchi P, et al. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer. Clin Cancer Res 2007;13(13):3831-9.
  5. Berg KD, Glaser CL, Thompson RE, et al. Detection of microsatellite instability by fluorescence multiplex polymerase chain reaction. J Mol Diagn 2000;2(1):20-8.
  6. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58(22): 5248-57.
  7. Oh JR, Kim DW, Lee HS, et al. Microsatellite instability testing in Korean patients with colorectal cancer. Fam Cancer 2012;11(3):459-66.
  8. Vaniawala S, Acharya A, Parekh H, et al. Pattern of variation in the mono- and dinucleotide repeat microsatellites associated with lynch syndrome in an Indian population. Oncol Res Treat 2014;37(12):720-4.
  9. Zeinalian M, Emami MH, Salehi R, et al. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature. J Gastrointest Cancer 2015;46(2):118-25.
  10. Gonzalez ML, Causada-Calo N, Santino JP, et al. Universal determination of microsatellite instability using BAT26 as a single marker in an Argentine colorectal cancer cohort. Fam Cancer 2017(2017):1-8.
  11. Korphaisarn K, Pongpaibul A, Limwongse C, et al. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer. World J Gastroenterol 2015;21(3):926-34.
  12. Le DT, Durham JN, Smith KN, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 2017;357(6349):409-13.
  13. Viale G, Trapani D, Curigliano G. Mismatch repair deficiency as a predictive biomarker for immunotherapy efficacy. Biomed Res Int 2017(2017):1-7.
  14. Chang L, Chang M, Chang HM, et al.Microsatellite instability: a predictive biomarker for cancer immunotherapy. Appl Immunohistochem Mol Morphol 2018;26(2):15-21. 
  15. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96(4):261-8.
  16. Le DT, Uram JN, Wang H, et al. PD-1 blockage in tumors with mismatch-repair deficiency. N Engl J Med 2015;372(26):2509-20.
SEARCH VOLUME & NUMBER
GO
RECENT VOLUME & NUMBER